Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

China-based MindRank’s oral glucagon-like peptide-1 receptor agonist (GLP-1RA) has achieved up to 10.5% weight loss in a ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

MDR-001 achieved statistically significant weight reductions of 8.2% to 10.3% at 24 weeks compared to 2.5% with placebo ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...

The GLP-1 receptor agonists decrease HbA 1c by stimulating glucose-dependent insulin secretion and by reducing glucagon secretion, gastric emptying, and appetite. 4,5 GLP-1 receptor agonist treatment ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

Verdiva Bio Limited ("Verdiva" or "the Company") a clinical-stage biopharmaceutical company focused on developing innovative ...